Metforal

Metformin Hydrochloride, the active ingredient in Metforal, is a biguanide presented as a tablet for oral use. It treats type 2 diabetes mellitus in adults by improving blood glucose control. GNH USA supplies Metforal as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metforal belongs to the biguanide class and is used to manage disorders of glucose metabolism. - Type 2 diabetes mellitus: improves glycemic control and reduces HbA1c levels. - Impaired glucose tolerance (prediabetes): lowers the risk of progression to type 2 diabetes. - Polycystic ovary syndrome: enhances insulin sensitivity and helps regulate menstrual cycles.

Metforal may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Gastrointestinal upset: nausea, abdominal discomfort, or diarrhea. - Metallic taste in the mouth. - Weight loss: modest reduction in body weight. - Vitamin B12 deficiency: decreased absorption with long‑term use. - Lactic acidosis (rare): symptoms include fatigue, rapid breathing, and abdominal pain.

Serious or Rare Side Effects: - Severe hypoglycemia when combined with insulin or sulfonylureas. - Hepatic dysfunction: elevated liver enzymes. - Allergic reactions: rash, pruritus, or angioedema. - Renal impairment: worsening kidney function in susceptible patients.

Before initiating Metforal, clinicians should evaluate patient‑specific factors and monitor for potential complications. - Renal function: assess creatinine clearance and avoid use in severe renal impairment. - Lactic acidosis risk: discontinue if patient develops unexplained acidosis or severe hypoxia. - Vitamin B12 monitoring: consider periodic testing during long‑term therapy. - Concomitant alcohol use: advise moderation to reduce lactic acidosis risk. - Pregnancy and breastfeeding: discuss potential risks with a healthcare professional. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Metforal can interact with several medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Iodinated contrast agents: may precipitate acute renal failure and increase lactic acidosis risk. - Cimetidine: can raise plasma metformin concentrations, enhancing toxicity.

Moderate Interactions (Monitor Closely): - Alcohol: synergistic effect on lactic acidosis. - Beta‑blockers: may mask hypoglycemia symptoms. - Diuretics (especially thiazides): can affect renal clearance of metformin. - Certain antiretrovirals (e.g., protease inhibitors): may increase metformin levels.